Cargando…
New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis
Autores principales: | Lee, Yong Sun, Yu, Ji Eun, Kim, Min Ji, Ham, Hyeon Joo, Jeon, Seong Hee, Yun, Jaesuk, Song, Suk‐Gil, Lee, Chong‐Kil, Han, Sang Bae, Son, Dong Ju, Hong, Jin Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858621/ https://www.ncbi.nlm.nih.gov/pubmed/35184414 http://dx.doi.org/10.1002/ctm2.739 |
Ejemplares similares
-
Improved Anti-Inflammatory Effects of Liposomal Astaxanthin on a Phthalic Anhydride-Induced Atopic Dermatitis Model
por: Lee, Yong Sun, et al.
Publicado: (2020) -
Microbiome in the Gut-Skin Axis in Atopic Dermatitis
por: Lee, So-Yeon, et al.
Publicado: (2018) -
Effectiveness and Safety of Herbal Medicine for Atopic Dermatitis: An Overview of Systematic Reviews
por: Kwon, Chan-Young, et al.
Publicado: (2020) -
Consensus Update for Systemic Treatment of Atopic Dermatitis
por: Lee, Ji Hyun, et al.
Publicado: (2021) -
Anti‐Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization
por: Yu, Ji Eun, et al.
Publicado: (2021)